Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117

NCT02505191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: St. John's wort prolonged-release tablet 500 mg
DRUG: St. John's wort film coated tablets 250 mg

Sponsor

Max Zeller Soehne AG